top of page

Innovative Financing for Cell and Gene Therapies

The emergence of gene therapy and other transformative therapies has magnified concerns about affordability among payers, providers and patients. In this report, I assess novel payment innovation such as performance contracts, annuities, reinsurance/stop loss, and subscription models.

Neumann U. (2020). Innovative Financing for Novel Therapies. Certara.



bottom of page